APA (7th ed.) Citation

WC, W., SK, B., GM, C., KU, E., W, L., T, M., . . . P, R. (2025). Vascular Access Thrombosis Events in Patients With Dialysis-Dependent CKD Treated With Vadadustat or Darbepoetin Alfa: The INNO2VATE Trial Program. Kidney medicine, 7(5), 100997. https://doi.org/10.1016/j.xkme.2025.100997

Chicago Style (17th ed.) Citation

WC, Winkelmayer, Burke SK, Chertow GM, Eckardt KU, Luo W, Minga T, Sarnak MJ, and Roy-Chaudhury P. "Vascular Access Thrombosis Events in Patients With Dialysis-Dependent CKD Treated With Vadadustat or Darbepoetin Alfa: The INNO2VATE Trial Program." Kidney Medicine 7, no. 5 (2025): 100997. https://doi.org/10.1016/j.xkme.2025.100997.

MLA (9th ed.) Citation

WC, Winkelmayer, et al. "Vascular Access Thrombosis Events in Patients With Dialysis-Dependent CKD Treated With Vadadustat or Darbepoetin Alfa: The INNO2VATE Trial Program." Kidney Medicine, vol. 7, no. 5, 2025, p. 100997, https://doi.org/10.1016/j.xkme.2025.100997.